SCHEDULE 13D/A: Amberjack Capital Group Amends Innovex International Stake, Appoints New Board Member

Amberjack Capital Partners and its affiliated entities have updated their beneficial ownership in Innovex International, Inc. to 42.4% and appointed Will Donnell to the company's Board of Directors.

Summary

• Amberjack Capital Partners, along with its affiliated funds and entities, collectively known as the Reporting Persons, beneficially own an aggregate of 29,369,822 shares of Innovex International, Inc. Common Stock.
• This aggregate ownership represents 42.4% of the Issuer's 69,261,035 outstanding Common Stock shares as of February 26, 2025.
• Key individual fund holdings include Amberjack Capital Fund II with 21,773,618 shares (31.4%), Innovex Co-Invest Fund II with 5,083,965 shares (7.3%), and Innovex Co-Invest Fund with 1,204,903 shares (1.7%).
• Intervale Capital Fund II holds 1,039,364 shares (1.5%), Intervale Capital Fund III holds 267,457 shares (0.4%), and Intervale Capital Fund II-A holds 515 shares (less than 0.1%).
• Jason Turowsky, as managing partner of Amberjack Management, is deemed the beneficial owner of the entire 29,369,822 shares.
• Will Donnell was appointed to the Board of Directors as an Amberjack Designee on March 3, 2025, replacing W. Patrick Connelly.

Sentiment

Score: 6

Explanation: The document is primarily a factual disclosure of beneficial ownership and a board change. The appointment of a new board member by a significant shareholder group can be viewed as a positive for governance and strategic alignment, hence a slightly positive score, but it lacks financial or operational details to warrant a higher sentiment.

Positives

• The appointment of Will Donnell as an Amberjack Designee to the Board of Directors indicates active engagement by a significant shareholder group, potentially leading to enhanced oversight and strategic alignment.
• The substantial beneficial ownership stake of 42.4% by Amberjack Capital Partners and its affiliates demonstrates a strong, concentrated interest in Innovex International, Inc.'s performance and future direction.

Negatives

• NA

Risks

• NA

Future Outlook

This filing is a disclosure of beneficial ownership and a board appointment, and does not contain forward-looking statements or guidance regarding the Issuer's operational or financial performance.

Industry Context

This Schedule 13D filing primarily concerns changes in beneficial ownership and board representation for Innovex International, Inc., reflecting an investor's updated stake and influence. It does not provide information to analyze broader industry trends or competitive positioning.

Management Changes

Corporate Governance

Legal Proceedings

• None of the Reporting Persons have been convicted in a criminal proceeding (excluding traffic violations or similar misdemeanors) during the past five years.
• None of the Reporting Persons have been a party to a civil proceeding of a judicial or administrative body of competent jurisdiction resulting in a judgment, decree, or final order enjoining future violations of, or prohibiting or mandating activities subject to, federal or state securities laws, or finding any violation with respect to such laws, during the past five years.

Stakeholder Impact

• Shareholders: The significant beneficial ownership by Amberjack Capital Partners and the appointment of their designee to the board could lead to more aligned strategic decisions and potentially influence shareholder value.
• Management: The new board member may bring new perspectives and oversight, potentially impacting management's operational autonomy and strategic focus.

Key Dates

Keywords

Schedule 13D, Beneficial Ownership, Innovex International Inc., Amberjack Capital Partners, Board Appointment, Corporate Governance, Investment Advisor, Common Stock